Jinhai International Group Holdings Limited ( (HK:2225) ) has shared an announcement.
Jinhai Medical Technology Limited has announced a board meeting scheduled for 28 March 2025 to discuss and approve the company’s annual results for the year ending 31 December 2024. The meeting will also consider the payment of a final dividend, which could have implications for shareholders and the company’s financial positioning.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited operates in the medical technology industry, focusing on the development and provision of medical products and services. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: -27.37%
Average Trading Volume: 4,484,712
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$7.03B
See more insights into 2225 stock on TipRanks’ Stock Analysis page.